These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17884593)

  • 21. Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?
    Thompson SG; Higgins JP
    Lancet; 2005 Jan 22-28; 365(9456):341-6. PubMed ID: 15664231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Credibility of claims of subgroup effects in randomised controlled trials: systematic review.
    Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
    BMJ; 2012 Mar; 344():e1553. PubMed ID: 22422832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation of subgroup effects in published trials.
    Hancock MJ; Kjaer P; Korsholm L; Kent P
    Phys Ther; 2013 Jun; 93(6):852-9. PubMed ID: 23431217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?
    Hernández AV; Boersma E; Murray GD; Habbema JD; Steyerberg EW
    Am Heart J; 2006 Feb; 151(2):257-64. PubMed ID: 16442886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The practice of systematic reviews. V. Heterogeneity between studies and subgroup analysis].
    Scholten RJ; Assendelft WJ; Kostense PJ; Bouter LM
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):843-8. PubMed ID: 10347653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic analysis across studies to drive knowledge-integration: A tutorial on individual patient data meta-analysis (IPDMA).
    van Wijk RC; Imperial MZ; Savic RM; Solans BP
    CPT Pharmacometrics Syst Pharmacol; 2023 Sep; 12(9):1187-1200. PubMed ID: 37303132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic reviews and meta-analysis for the surgeon scientist.
    Mahid SS; Hornung CA; Minor KS; Turina M; Galandiuk S
    Br J Surg; 2006 Nov; 93(11):1315-24. PubMed ID: 17058324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculating the power to examine treatment-covariate interactions when planning an individual participant data meta-analysis of randomized trials with a binary outcome.
    Riley RD; Hattle M; Collins GS; Whittle R; Ensor J
    Stat Med; 2022 Oct; 41(24):4822-4837. PubMed ID: 35932153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misuse of baseline comparison tests and subgroup analyses in surgical trials.
    Bhandari M; Devereaux PJ; Li P; Mah D; Lim K; Schünemann HJ; Tornetta P
    Clin Orthop Relat Res; 2006 Jun; 447():247-51. PubMed ID: 16672904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-regression analysis shows no impact of design characteristics on outcome in trials on tension-type headaches.
    Verhagen AP; de Vet HC; Willemsen S; Stijnen T
    J Clin Epidemiol; 2008 Aug; 61(8):813-8. PubMed ID: 18359608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual patient meta-analysis--rewards and challenges.
    van Walraven C
    J Clin Epidemiol; 2010 Mar; 63(3):235-7. PubMed ID: 19595573
    [No Abstract]   [Full Text] [Related]  

  • 34. How to read and understand and use systematic reviews and meta-analyses.
    Leucht S; Kissling W; Davis JM
    Acta Psychiatr Scand; 2009 Jun; 119(6):443-50. PubMed ID: 19469725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic reviews and meta-analyses of randomized trials: principles and pitfalls.
    da Costa BR; Juni P
    Eur Heart J; 2014 Dec; 35(47):3336-45. PubMed ID: 25416325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
    Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
    J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of systematic reviews and meta-analyses in pediatric nutrition.
    Szajewska H
    World Rev Nutr Diet; 2013; 108():1-10. PubMed ID: 24029781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating systematic reviews and meta-analyses.
    Schlesselman JJ; Collins JA
    Semin Reprod Med; 2003 Feb; 21(1):95-105. PubMed ID: 12806564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners.
    Fisher DJ; Copas AJ; Tierney JF; Parmar MK
    J Clin Epidemiol; 2011 Sep; 64(9):949-67. PubMed ID: 21411280
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.